Showing 43‐47 of 47
results per page
technology
Light Path™ Protein Production
Light Path™ Protein Production – gene to product offerings supporting preclinical and phase I studies for microbial or mammalian proteins.
technology
Multiparticulate Technologies
We utilize four multiparticulate technologies for meeting target product profiles, with the choice being dependent upon API parameters, formulation requirements and commercial objectives.
technology
Nucleofector™ Products
Nucleofector™ Products for efficient non-viral modification of primary cells, enabling generation of iPSC or CAR-T cells, or CRISPR-mediated engineering.
technology
Osmotic Tablet Technologies
We use two osmotic tablet technologies that are highly flexible, can be utilized with both crystalline and amorphous drug substances, and utilize osmotic/hydrostatic pressure to provide consistent drug release without food effect.
technology
Technology Selection
We have developed models, reference tools and methodologies to accelerate technology selection for BCS II compounds.
< 1 2 3